Investing.com -- Sanofi SA (EPA:SASY) announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application of tolebrutinib, which was ...
Keeping an organized record and schedule of your applications can streamline the process as deadlines near, and the holiday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback